Stockreport

Roche Gets FDA Approval for Acute Ischemic Stroke Drug for Adults [Yahoo! Finance]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF As a result of the approval, Genentech has the only two FDA-approved medicines to treat AIS in its portfolio, namely TNKase and Activase (alteplase). TNKase is a tiss [Read more]